Everolimus for refractory Crohn's disease: a case report.
about
Etiology of Crohn's disease: many roads lead to autophagy.Medical therapy of stricturing Crohn's disease: what the gut can learn from other organs - a systematic review.Digesting the genetics of inflammatory bowel disease: insights from studies of autophagy risk genes.TSC2/mTORC1 signaling controls Paneth and goblet cell differentiation in the intestinal epithelium.Intestinal Autophagy and Its Pharmacological Control in Inflammatory Bowel Disease.Autophagy and Crohn's disease: at the crossroads of infection, inflammation, immunity, and cancer.Mechanisms of initiation and progression of intestinal fibrosis in IBD.Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles.Basiliximab treatment for autoimmune bowel disease in a pediatric heart transplant patient.Localization of ανβ6 integrin-TGF-β1/Smad3, mTOR and PPARγ in experimental colorectal fibrosis.Cellular and molecular mechanisms of intestinal fibrosis.Anti-TNF Antibodies and Autophagy: A Hidden Nexus for a Successful Therapeutic Response?Epithelial-mesenchymal transition in Crohn's disease.Biopsy-derived Intestinal Epithelial Cell Cultures for Pathway-based Stratification of Patients With Inflammatory Bowel Disease.Sirolimus in Refractory Cronkhite-Canada Syndrome and Focus on Standard Treatment.Boosting mTOR-dependent autophagy via upstream TLR4-MyD88-MAPK signalling and downstream NF-κB pathway quenches intestinal inflammation and oxidative stress injury
P2860
Q34288268-C4F3E705-55BF-4BAA-B181-0751DE1D5077Q34504710-5B59FEE9-0B76-4E08-B000-17FE3DFF3C09Q35633085-F2150727-483C-497D-8E5B-DCF1E0E88C04Q36347242-B13A1512-D48C-49B5-A7DF-442C3FF705FAQ37570542-0D4C3C53-8E3F-47E8-85A7-B7F61254D864Q37764367-6D6A3104-3DA9-4B5A-A1D0-24420C5BF5FEQ38293779-186F6977-D4C7-4E83-9BD5-46CACE4BFFCEQ39321120-D777799C-3803-4FA0-8B56-BE7DF5588D0BQ40139185-63F954AC-20EE-4E90-BB30-A71107B147F1Q41879637-65467728-EBE5-4B81-9470-430C05B6E76BQ42252132-C1693B74-6D3E-4EEB-BB51-0072DB804EE3Q42408122-66699DE1-8B79-4D7C-8239-8E8405AFAA32Q49965391-A93E28BC-38DA-4B58-B520-90E3B8E6EA52Q50065054-5A13DEE1-6247-46FB-8C89-4A80F3BBA7D6Q55049043-A1E1D547-EE07-4E36-AC97-9447E5899543Q58692935-09CA0E3B-4128-4AC5-8D89-9215876A9411
P2860
Everolimus for refractory Crohn's disease: a case report.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Everolimus for refractory Crohn's disease: a case report.
@en
Everolimus for refractory Crohn's disease: a case report.
@nl
type
label
Everolimus for refractory Crohn's disease: a case report.
@en
Everolimus for refractory Crohn's disease: a case report.
@nl
prefLabel
Everolimus for refractory Crohn's disease: a case report.
@en
Everolimus for refractory Crohn's disease: a case report.
@nl
P2093
P2860
P356
P1476
Everolimus for refractory Crohn's disease: a case report.
@en
P2093
Christian Partensky
Gilles Poncet
Jean-Yves Scoazec
Jérôme Dumortier
Marie-Claude Gagnieu
Marie-George Lapalus
Olivier Guillaud
P2860
P304
P356
10.1002/IBD.20395
P577
2008-06-01T00:00:00Z